Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Three win Nobel Prize for hepatitis C discoveries

Oct. 6, 2020

Sorrento initiates phase I study of COVI-GUARD in patients with moderate COVID-19

Oct. 5, 2020

Revelation Biosciences receives ethics committee approval for phase I study of REVTx-99 for COVID-19

Oct. 5, 2020

Enanta Pharmaceuticals patents new antivirals

Oct. 5, 2020

Baylx gets IND approval to conduct study of BX-U001 in patients with COVID-19

Oct. 2, 2020

Stem cells can help stem Klebsiella infection

Oct. 2, 2020

Sorrento and ViralClear to explore combination therapy against COVID-19

Oct. 2, 2020

Enlivex reports data on use of Allocetra in COVID-19 patients in severe or critical condition

Oct. 1, 2020

MedinCell begins the first study of its COVID-19 prevention program

Oct. 1, 2020

First patients dosed in phase IIa study of COVID-19 vaccine candidate, CVnCoV

Oct. 1, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...